semaglutide and suicide risk Association of with of suicidal ideation in a real-world cohort Drugs like Ozempic, Wegovy and

Patients carrying specific GLP-1R or GIPR variants may experience differential sensitivity to GLP-1 agonists, while FTO and MC4R variants relate to baseline metabolic risk and satiety signaling

When appetite is low, convenience really matters. Nutrition During Maintenance For those tapering down or transitioning into maintenance, patience is essential

Other GLP-1 receptor agonists and various weight loss interventionswhether pharmacological, dietary, or surgicalare also associated with increased gallbladder-related risks, though the magnitude may vary by approach and agent

In a 40-week SURPASS-2 trial, 1879 inadequately controlled type 2 diabetes patients were randomized to tirzepatide or semaglutide